Deutsch English Français

Contact

EP3768705

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP3768705

EP3768705 - MULTIVALENT BINDING MOLECULES [Right-click to bookmark this link]
Status	Request for examination was made Status updated on 25.12.2020 Database last updated on 25.09.2024
Former	The international publication has been made Status updated on 28.09.2019
Former	unknown Status updated on 20.04.2018
Most recent event Tooltip	22.03.2024	New entry: Renewal fee paid
Applicant(s)	For all designated states Universität Stuttgart Keplerstr. 7 70569 Stuttgart / DE
	[2021/04]
Inventor(s)	01 / SEIFERT, Oliver Zuffenhäuser Heide 1 70437 Stuttgart / DE
	02 / KONTERMANN, Roland Gothaer Str. 6 72622 Nürtingen / DE
	03 / RICHTER, Fabian Cranachweg 11 73230 Kirchheim unter Teck / DE
	[2021/04]
Representative(s)	Zwicker, Jörk ZSP Patentanwälte PartG mbB Hansastraße 32 80686 München / DE
	[2021/04]
Application number, filing date	18716145.0	22.03.2018
	[2021/04]
	WO2018EP57331
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2019179627
	Date:	26.09.2019
	Language:	EN
	[2019/39]
	Type:	A1 Application with search report
	No.:	EP3768705
	Date:	27.01.2021
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 26.09.2019 takes the place of the publication of the European patent application.
	[2021/04]
Search report(s)	International search report - published on:	EP	26.09.2019
Classification	IPC:	C07K16/18, C07K16/28, C07K16/32, C07K16/46	[2021/04]
	CPC:	C07K16/2878 (EP,US); C07K16/2863 (EP,US); A61K39/39533 (US); A61P35/00 (US); C07K16/32 (EP,US); C07K16/468 (EP); (+) A61K38/00 (US); C07K2317/30 (US); C07K2317/526 (EP,US); C07K2317/60 (EP,US); C07K2317/62 (EP,US); C07K2317/64 (EP,US); C07K2317/66 (EP,US); C07K2317/73 (EP,US); C07K2317/75 (EP,US); C07K2317/90 (EP); C07K2317/92 (EP,US); C07K2317/94 (EP,US); G01N33/5091 (US) (-)
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/04]
Title	German:	MULTIVALENTE BINDUNGSMOLEKÜLE	[2021/04]
	English:	MULTIVALENT BINDING MOLECULES	[2021/04]
	French:	MOLÉCULES DE LIAISON MULTIVALENTES	[2021/04]
Entry into regional phase	09.10.2020	National basic fee paid
	09.10.2020	Designation fee(s) paid
	09.10.2020	Examination fee paid
Examination procedure	09.10.2020	Examination requested [2021/04]
	09.10.2020	Date on which the examining division has become responsible
	05.05.2021	Amendment by applicant (claims and/or description)
Fees paid	Renewal fee
	09.10.2020	Renewal fee patent year 03
	22.03.2021	Renewal fee patent year 04
	22.03.2022	Renewal fee patent year 05
	22.03.2023	Renewal fee patent year 06
	21.03.2024	Renewal fee patent year 07
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[XI]WO0202781 (VLAAMS INTERUNIV INST BIOTECH [BE], et al) [X] 1,3-7,10,15 * page 8, line 19 - line 21 * * page 6, line 25 - line 28 * * figures 1,2 * [I] 2,8,9,11-14;
		[Y]WO2007024715 (ABBOTT LAB [US], et al) [Y] 1-15* figure 1 *;
		[A]WO2013156148 (UNIV STUTTGART [DE]) [A] 5-8 * page 1 - page 2 *;
		[XI]US2014213772 (GHAYUR TARIQ [US], et al) [X] 1-10,15 * paragraph [0128]; figure 1; claim 1 * [I] 11-14;
		[A] - SPIESS CHRISTOPH ET AL, "Alternative molecular formats and therapeutic applications for bispecific antibodies", MOLECULAR IMMUNOLOGY, PERGAMON, GB, (20150127), vol. 67, no. 2, doi:10.1016/J.MOLIMM.2015.01.003, ISSN 0161-5890, pages 95 - 106, XP029246892 [A] 1-15 * figure 1 * DOI: http://dx.doi.org/10.1016/j.molimm.2015.01.003
		[Y] - ANKE STEINMETZ ET AL, "CODV-Ig, a universal bispecific tetravalent and multifunctional immunoglobulin format for medical applications", MABS, US, (20160316), vol. 8, no. 5, doi:10.1080/19420862.2016.1162932, ISSN 1942-0862, pages 867 - 878, XP055343765 [Y] 1-15 * page 868, column 1, paragraph 1; figure 1 * DOI: http://dx.doi.org/10.1080/19420862.2016.1162932
	by applicant	US2003118592
		US2003133939
		- PRESTA, LG., "Molecular engineering and design of therapeutic antibodies", Curr Opin. Immunol., (20080000), vol. 20, doi:doi:10.1016/j.coi.2008.06.012, pages 460 - 470, XP025771205 DOI: http://dx.doi.org/10.1016/j.coi.2008.06.012
		- KONTERMANN, "Dual targeting strategies with bispecific antibodies", mAbs, (20120000), vol. 4, doi:doi:10.4161/mabs.4.2.19000, pages 182 - 197, XP009160769 DOI: http://dx.doi.org/10.4161/mabs.4.2.19000
		- GARBER K., "Bispecific antibodies rise again", Nat. Rev. Drug Discov., (20140000), vol. 13, doi:doi:10.1038/nrd4478, pages 799 - 801, XP055242329 DOI: http://dx.doi.org/10.1038/nrd4478
		- BRINKMANN; KONTERMANN, "The making of bispecific antibodies", mAbs, (20170000), vol. 9, doi:doi:10.1080/19420862.2016.1268307, pages 182 - 212, XP055374463 DOI: http://dx.doi.org/10.1080/19420862.2016.1268307
		- SEGAL et al., "Bispecific antibodies in cancer therapy", Curr. Opin. Immunol., (19990000), vol. 11, doi:doi:10.1016/S0952-7915(99)00015-1, pages 558 - 562, XP004257585 DOI: http://dx.doi.org/10.1016/S0952-7915(99)00015-1
		- KONTERMANN; BRINKMANN, "Bispecific antibodies", Drug Discov. Today, (20150000), vol. 20, doi:doi:10.1016/j.drudis.2015.02.008, pages 838 - 847, XP055251363 DOI: http://dx.doi.org/10.1016/j.drudis.2015.02.008
		- SPIESS et al., "Alternative molecular formats and therapeutic applications for bispecific antibodies", Mol. Immunol., (20150000), vol. 67, doi:doi:10.1016/j.molimm.2015.01.003, pages 95 - 106, XP029246892 DOI: http://dx.doi.org/10.1016/j.molimm.2015.01.003
		- WARD et al., Nature, (19890000), vol. 341, pages 544 - 546
		- BIRD et al., Science, (19880000), vol. 242, pages 423 - 426
		- HUSTON et al., Proc. Natl. Acad. Sci. USA, (19880000), vol. 85, pages 5879 - 5883
		- HOLLIGER P. et al., Proc. Natl. Acad. Sci. U.S.A., (19930000), vol. 90, no. 14, pages 6444 - 6448
		- BRODY E.N.; GOLD L., "Aptamers as therapeutic and diagnostic agents", J. Biotechnol., (20000000), vol. 74, no. 1, pages 5 - 13, XP009031105
		- BINZ H.K. et al., "Engineering novel binding proteins from nonimmunoglobulin domains", Nat. Biotechnol., (20050000), vol. 23, no. 10, doi:doi:10.1038/nbt1127, pages 1257 - 1268, XP002381839 DOI: http://dx.doi.org/10.1038/nbt1127
		- SMITH; WATERMAN, Adv. Appl. Math., (19700000), vol. 2, page 482
		- NEEDLEMAN; WUNSCH, J. Mol. Biol., (19700000), vol. 48, page 443
		- PEARSON; LIPMAN, Proc. Natl. Acad. Sci. USA, (19880000), vol. 85, page 2444
		- ALTSCHUL et al., Nuc. Acids Res., (19770000), vol. 25, pages 3389 - 3402
		- ALTSCHUL et al., J. Mol. Biol., (19900000), vol. 215, pages 403 - 410
		- HENIKOFF; HENIKOFF, Proc. Natl. Acad. Sci. USA, (19890000), vol. 89, page 10915
		- KARLIN; ALTSCHUL, Proc. Natl. Acad. Sci. USA, (19930000), vol. 90, pages 5873 - 5887
		- NIELSEN et al., Science, (19910000), vol. 254, pages 1497 - 1500
		- CHUDAKOV et al., Physiol. Rev., (20100000), vol. 90, pages 1103 - 1163

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p